Last reviewed · How we verify

Placebo and prednisone

Janssen Research & Development, LLC · Phase 3 active Small molecule

This is a comparator arm combining placebo with prednisone, a corticosteroid that suppresses immune function and reduces inflammation.

This is a comparator arm combining placebo with prednisone, a corticosteroid that suppresses immune function and reduces inflammation. Used for Active comparator arm in phase 3 clinical trial (specific indication unknown).

At a glance

Generic namePlacebo and prednisone
SponsorJanssen Research & Development, LLC
Drug classCorticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaImmunology
PhasePhase 3

Mechanism of action

Prednisone is a systemic corticosteroid that works by binding to glucocorticoid receptors and suppressing T-cell activation, cytokine production, and inflammatory responses. In this phase 3 trial, it serves as an active comparator control arm against which an investigational Janssen therapy is being evaluated. The placebo component indicates this is a blinded trial design.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: